+49 30 648 35 164 service@chameleon-pharma.com


Streets of Cartagena Old Town Colombia

Featured image: Photo by Ricardo Gomez Angel on Unsplash

The OTC and pharma market in Colombia 

Cur­rently worth US $4.2 billion, the Colom­bian Health­care mar­ket may seem small in com­par­i­son to its neigh­bours, but the mar­ket is set to expand at a one-digit CAGR between 2013 and 2016.

The eco­nomic and polit­i­cal envi­ron­ment is sta­ble, so the out­look is pos­i­tive for phar­ma­ceu­ti­cal mar­ket growth. Colom­bia is look­ing for­ward to increasing drug access for the whole pop­u­la­tion under a uni­ver­sal insur­ance pro­gram, which will imme­di­ately expand the mar­ket. Imports, exports and the num­ber of Pharma com­pa­nies oper­at­ing in the mar­ket are also ris­ing. The cur­rent lead­ing phar­ma­ceu­ti­cal com­pany in Colom­bia is Tec­no­quim­i­cas, fol­lowed by Bax­ter and Roche; its largest domes­tic man­u­fac­tur­ers are Bussie, Gen­far and Lafran­col (who pro­duce generic copy­cats).


The Colombian OTC and pharma market in 2030

USD 10,9 Billion

OTC and pharma market size


OTC and pharma market growth

Colombia in numbers

Total population


Population growth

Birth rate

Mortality rate

Life expectancy

Interested in this market?


We are ready to support you in Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory projects, and more in order to ensure your growth.